Ayako Maeda

Oral administration of Bifidobacterium bifidum G9-1 alleviates rotavirus gastroenteritis through regulation of intestinal homeostasis by inducing mucosal protective factors

Tomohiro Kawahara, Yutaka Makizaki, Yosuke Oikawa et al. · PLoS ONE · 2017 · 54 citations · Full text

Dysbiosis, Immunology, Gastroenterology +17

Gut microbiota composition associated with hepatic fibrosis in non‐obese patients with non‐alcoholic fatty liver disease

Michihiro Iwaki, Takaomi Kessoku, Anna Ozaki et al. · Journal of Gastroenterology and Hepatology · 2021 · 39 citations

Diarrhea-predominant Irritable Bowel Syndrome-like Symptoms in Patients With Quiescent Crohn’s Disease: Comprehensive Analysis of Clinical Features and Intestinal Environment Including the Gut Microbiome, Organic Acids, and Intestinal Permeability

Toshihiko Tomita, Hirokazu Fukui, Daisuke Morishita et al. · Journal of Neurogastroenterology and Motility · 2023 · 35 citations · Full text

Alteration of Colonic Mucosal Permeability during Antibiotic-Induced Dysbiosis

Ying Ran, Hirokazu Fukui, Xin Xu et al. · International Journal of Molecular Sciences · 2020 · 34 citations · Full text

Antibiotic-induced Dysbiosis, Dysbiosis, Microbial Pathogens +19

Alleviation of low-fiber diet-induced constipation by probiotic <i>Bifidobacterium bifidum</i> G9-1 is based on correction of gut microbiota dysbiosis

Yutaka Makizaki, Ayako Maeda, Yosuke Oikawa et al. · Bioscience of Microbiota Food and Health · 2018 · 24 citations · Full text